l'oreal-unsponsored adr (LRLCY) Key Developments
L'Oreal SA, Board Meeting, Feb 10, 2014
Feb 12 14
L'Oreal SA, Board Meeting, Feb 10, 2014. Agenda: To approve the decision of voting members a strategic transaction for Nestle and L'Oreal under which L'Oreal will buy 48.5 million of its own shares from Nestle.
L'Oreal Proposes Increased Dividend
Feb 11 14
The Board of Directors of L'Oreal has decided to propose to the Annual General Meeting of April 17, 2014 the payment of a dividend of EUR 2.50 per share, an increase of 8.7% compared with the previous year.
L'Oreal SA, Nestlé S.A. - Special Call
Feb 11 14
To discuss strategic transaction under which L'Oréal will buy 48.5 million of its own shares from Nestlé
L'Oreal Proposes Dividend Payment
Feb 10 14
L'Oreal announced that the company's board proposed increasing the dividend payment by 8.7% to EUR 2.50 per share.
Evolva Holding SA Enters into Collaboration Agreement with L'Oréal for Co-Development of Novel Biosynthetic Production Routes for Undisclosed Ingredient with Broad Applications in Cosmetics Industry
Feb 10 14
Evolva Holding SA announced that it has signed a collaboration agreement with L'Oréal for the co-development of novel biosynthetic production routes for an undisclosed ingredient with broad applications in the cosmetics industry. Evolva and L'Oréal will apply Evolva's fermentation technology platform to develop and optimise yeast strains for the sustainable, cost-effective production of this strategically important cosmetics ingredient. This collaboration will begin immediately and conclude in late 2016, and includes an option to expand the ingredient focus. L'Oréal will pay Evolva research fees during the project period. Additionally, Evolva is eligible to receive milestone payments based on achieving research objectives.